Jinmao Liao
Changsha, 410005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Therapeutic potential and mechanisms of Rifaximin in ameliorating iron overload-induced ferroptosis and liver fibrosis in vivo and in vitro.
Journal: Toxicology and applied pharmacology
Published: October 06, 2023
LPS Activated Macrophages Induced Hepatocyte Pyroptosis via P2X7R Activation of NLRP3 in Mice.
Journal: Iranian journal of immunology : IJI
Published: March 16, 2022
The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl4-caused liver fibrosis.
Journal: Toxicology letters
Published: January 05, 2022
Rifaximin protects SH-SY5Y neuronal cells from iron overload-induced cytotoxicity via inhibiting STAT3/NF-κB signaling.
Journal: Cell biology international
Published: April 23, 2021
VEGF165 gene-modified human umbilical cord blood mesenchymal stem cells protect against acute liver failure in rats.
Journal: The journal of gene medicine
Published: April 19, 2021
A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation.
Journal: Toxicology letters
Published: May 30, 2020
LncRNA DRAIC inhibits proliferation and metastasis of gastric cancer cells through interfering with NFRKB deubiquitination mediated by UCHL5.
Journal: Cellular & molecular biology letters
Published: December 14, 2019
Therapeutic effect of human umbilical cord blood mesenchymal stem cells combined with G-CSF on rats with acute liver failure.
Journal: Biochemical and biophysical research communications
Published: July 09, 2019
miR-374a/Myc axis modulates iron overload-induced production of ROS and the activation of hepatic stellate cells via TGF-β1 and IL-6.
Journal: Biochemical and biophysical research communications
Published: May 05, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026